DOX — Doxee SpA Income Statement
0.000.00%
Last trade - 00:00
- €18.42m
- €36.49m
- €25.46m
- 13
- 46
- 12
- 12
2018 December 31st | 2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | — | IAS | IAS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 13.7 | 15.5 | 17.7 | 20.8 | 25.5 |
Cost of Revenue | |||||
Gross Profit | 11.7 | 10.7 | 13.2 | 14 | 15.8 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 12.7 | 13.2 | 15.6 | 18.9 | 23.7 |
Operating Profit | 1.04 | 2.26 | 2.15 | 1.94 | 1.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1 | 2.11 | 1.52 | 2 | 1.63 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.601 | 1.7 | 0.927 | 1.77 | 1.25 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 0.601 | 1.7 | 0.94 | 1.79 | 1.24 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.601 | 1.7 | 0.94 | 1.79 | 1.24 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.084 | 0.237 | 0.131 | 0.25 | 0.144 |
Dividends per Share |